Award

ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack

  • Belfast Health & Social Care Trust

UK5: Transparency notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-030827

Procurement identifier (OCID): ocds-h6vhtk-054508 (view related notices)

Published 9 June 2025, 10:13am



Scope

Reference

DACPM2025-24

Description

Procurement of ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack


Contract 1. ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack

Supplier

Contract value

  • £1,200,000 excluding VAT
  • £1,200,000 including VAT

Above the relevant threshold

Earliest date the contract will be signed

16 June 2025

Contract dates (estimated)

  • 17 June 2025 to 30 June 2027
  • 2 years, 14 days

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Contract locations

  • UKN - Northern Ireland

Other information

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Direct award

Direct award justification

Single supplier - intellectual property or exclusive rights

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.


Supplier

PIERRE FABRE LIMITED

  • Companies House: 00986738
  • Public Procurement Organisation Number: PRHQ-6453-ZCGD

1 Fleet Place

London

EC4M 7WS

United Kingdom

Region: UKI43 - Haringey and Islington

Contract 1. ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack


Contracting authority

Belfast Health & Social Care Trust

  • Public Procurement Organisation Number: PLQJ-5727-JCLR

Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital

Belfast

BT12 6BA

United Kingdom

Region: UKN06 - Belfast

Organisation type: Public authority - central government

Devolved regulations that apply: Northern Ireland